These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30009892)

  • 1. Targeting sialic acid residues on lung cancer cells by inhalable boronic acid-decorated albumin nanocomposites for combined chemo/herbal therapy.
    Elgohary MM; Helmy MW; Abdelfattah EA; Ragab DM; Mortada SM; Fang JY; Elzoghby AO
    J Control Release; 2018 Sep; 285():230-243. PubMed ID: 30009892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-targeted nano-in-nano albumin carriers enhance the efficacy of combined chemo/herbal therapy of lung cancer.
    Elgohary MM; Helmy MW; Mortada SM; Elzoghby AO
    Nanomedicine (Lond); 2018 Sep; 13(17):2221-2224. PubMed ID: 30265215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalable multi-compartmental phospholipid enveloped lipid core nanocomposites for localized mTOR inhibitor/herbal combined therapy of lung carcinoma.
    Kabary DM; Helmy MW; Abdelfattah EA; Fang JY; Elkhodairy KA; Elzoghby AO
    Eur J Pharm Biopharm; 2018 Sep; 130():152-164. PubMed ID: 29964122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalable lactoferrin-chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma.
    Abd Elwakil MM; Mabrouk MT; Helmy MW; Abdelfattah EA; Khiste SK; Elkhodairy KA; Elzoghby AO
    Nanomedicine (Lond); 2018 Aug; 13(16):2015-2035. PubMed ID: 30191764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer functionalized curcumin-loaded human serum albumin (HSA) nanoparticles for targeted delivery to HER-2 positive breast cancer cells.
    Saleh T; Soudi T; Shojaosadati SA
    Int J Biol Macromol; 2019 Jun; 130():109-116. PubMed ID: 30802519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional nanoparticles co-delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non-small-cell lung tumor.
    Yuan ZQ; Chen WL; You BG; Liu Y; Yang SD; Li JZ; Zhu WJ; Zhou XF; Liu C; Zhang XN
    J Control Release; 2017 Dec; 268():198-211. PubMed ID: 29061511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma.
    Kabary DM; Helmy MW; Elkhodairy KA; Fang JY; Elzoghby AO
    Colloids Surf B Biointerfaces; 2018 Sep; 169():183-194. PubMed ID: 29775813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation.
    Qu N; Sun Y; Li Y; Hao F; Qiu P; Teng L; Xie J; Gao Y
    Biomed Eng Online; 2019 Jan; 18(1):11. PubMed ID: 30704488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhalable Lactoferrin/Chondroitin-Functionalized Monoolein Nanocomposites for Localized Lung Cancer Targeting.
    Abdelaziz HM; Elzoghby AO; Helmy MW; Abdelfattah EA; Fang JY; Samaha MW; Freag MS
    ACS Biomater Sci Eng; 2020 Feb; 6(2):1030-1042. PubMed ID: 33464839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue.
    Abbas Y; Azzazy HM; Tammam S; Lamprecht A; Ali ME; Schmidt A; Sollazzo S; Mathur S
    Colloids Surf B Biointerfaces; 2016 Oct; 146():19-30. PubMed ID: 27244047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoted Antitumor Activity of Myricetin against Lung Carcinoma Via Nanoencapsulated Phospholipid Complex in Respirable Microparticles.
    Nafee N; Gaber DM; Elzoghby AO; Helmy MW; Abdallah OY
    Pharm Res; 2020 Apr; 37(4):82. PubMed ID: 32291520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer.
    Choi SH; Byeon HJ; Choi JS; Thao L; Kim I; Lee ES; Shin BS; Lee KC; Youn YS
    J Control Release; 2015 Jan; 197():199-207. PubMed ID: 25445703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung.
    Athawale RB; Jain DS; Singh KK; Gude RP
    Biomed Pharmacother; 2014 Mar; 68(2):231-40. PubMed ID: 24560352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HA/HSA co-modified erlotinib-albumin nanoparticles for lung cancer treatment.
    Shen Y; Li W
    Drug Des Devel Ther; 2018; 12():2285-2292. PubMed ID: 30087553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery.
    Wang Z; Li Z; Zhang D; Miao L; Huang G
    Drug Deliv; 2015 Jan; 22(1):79-85. PubMed ID: 24401038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhalable Dual-Targeted Hybrid Lipid Nanocore-Protein Shell Composites for Combined Delivery of Genistein and All-Trans Retinoic Acid to Lung Cancer Cells.
    Kamel NM; Helmy MW; Abdelfattah EZ; Khattab SN; Ragab D; Samaha MW; Fang JY; Elzoghby AO
    ACS Biomater Sci Eng; 2020 Jan; 6(1):71-87. PubMed ID: 33463208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates.
    Abdelaziz HM; Gaber M; Abd-Elwakil MM; Mabrouk MT; Elgohary MM; Kamel NM; Kabary DM; Freag MS; Samaha MW; Mortada SM; Elkhodairy KA; Fang JY; Elzoghby AO
    J Control Release; 2018 Jan; 269():374-392. PubMed ID: 29180168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer.
    Tomoda K; Ohkoshi T; Hirota K; Sonavane GS; Nakajima T; Terada H; Komuro M; Kitazato K; Makino K
    Colloids Surf B Biointerfaces; 2009 Jul; 71(2):177-82. PubMed ID: 19264458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of VEGF siRNA and Etoposide for Enhanced Anti-angiogenesis and Anti-proliferation Effect
    Li F; Wang Y; Chen WL; Wang DD; Zhou YJ; You BG; Liu Y; Qu CX; Yang SD; Chen MT; Zhang XN
    Theranostics; 2019; 9(20):5886-5898. PubMed ID: 31534526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer.
    Shukla SK; Kulkarni NS; Farrales P; Kanabar DD; Parvathaneni V; Kunda NK; Muth A; Gupta V
    Pharm Res; 2020 Mar; 37(3):67. PubMed ID: 32166411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.